Literature DB >> 7730625

Structure of the human C7 gene and comparison with the C6, C8A, C8B, and C9 genes.

M J Hobart1, B A Fernie, R G DiScipio.   

Abstract

The seventh component of complement is a single chain plasma glycoprotein that is involved in the cytolytic phase of complement activation. We have determined the structure of the C7 gene, which is encoded by 18 exons whose sizes vary from 56 to 244 bp. For the most part, the exons do not correspond to the protein homology units. However, two intron/exon boundaries occur at junctions between different functional parts of the protein. The first is at a site between the end of the C9 homology unit and the carboxyl-terminal extension which is also a feature of C6. The second of these boundaries occurs between the regions encoding two pairs of cysteine-rich modules (the short consensus repeats and the factor I modules) located in the carboxyl-terminal part of C7. In contrast to the exons, the introns range considerably in size from 0.5 to 8.5 kbp. The complete analysis indicates that the gene encoding C7 is approximately 80 kbp in length. We show here that the C7 gene is highly homologous to that for C6, and also to C8A, C8B, and C9, confirming and extending the published data. With the exception of exon 1, all intron/exon boundaries are preserved with respect to phase when compared with C6.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730625

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  Complement components 2 and 7 (C2 and C7) gene polymorphisms are not major risk factors for SLE susceptibility in the Malaysian population.

Authors:  Lay-Hoong Lian; Ai-Sze Ching; Zheng-Yi Chong; Kek-Heng Chua
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

3.  Molecular defects of the C7 gene in two patients with complement C7 deficiency.

Authors:  Sonia Barroso; Claudine Rieubland; Antonia José álvarez; Margarita López-Trascasa; Pierre-Alexandre Bart; Antonio Núñez-Roldán; Berta Sánchez
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

4.  Gene duplication of the seventh component of complement in rainbow trout.

Authors:  Anastasios D Papanastasiou; Ioannis K Zarkadis
Journal:  Immunogenetics       Date:  2005-10-18       Impact factor: 2.846

5.  Complement component C7 deficiency in a Spanish family.

Authors:  M F Vázquez-Bermúdez; S Barroso; K Walter; A J Alvarez; A Alarcón; M López-Trascasa; I Wichmann; F Aguilar; A Núñez-Roldán; B Sánchez
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

6.  Two novel mutations in the C7 gene in a Korean patient with complement C7 deficiency.

Authors:  Chang-Seok Ki; Jong-Won Kim; Hee-Jin Kim; Sung-Min Choi; Gyoung-Yim Ha; Hee Jung Kang; Won-Duck Kim
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

7.  C7 deficiency in an Irish family: a deletion defect which is predominant in the Irish.

Authors:  A M O'Hara; B A Fernie; A P Moran; Y E Williams; J J Connaughton; A Orren; M J Hobart
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

8.  Membrane pore formation by human complement: functional importance of the transmembrane β-hairpin (TMH) segments of C8α and C9.

Authors:  Mitch H Weiland; Yu Qian; James M Sodetz
Journal:  Mol Immunol       Date:  2013-11-12       Impact factor: 4.407

9.  Crystal structure of the MACPF domain of human complement protein C8 alpha in complex with the C8 gamma subunit.

Authors:  Daniel J Slade; Leslie L Lovelace; Maksymilian Chruszcz; Wladek Minor; Lukasz Lebioda; James M Sodetz
Journal:  J Mol Biol       Date:  2008-04-03       Impact factor: 5.469

10.  A novel mutation in a patient with a deficiency of the eighth component of complement associated with recurrent meningococcal meningitis.

Authors:  D F Arnold; A G Roberts; A Thomas; B Ferry; B P Morgan; H Chapel
Journal:  J Clin Immunol       Date:  2009-05-12       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.